-
Yet despite the muddle over what the markers of class are these days, 71% of those polled by YouGov still said they found it very or fairly easy to figure out which class others belong to.
ECONOMIST: Class
-
Most approved cholesterol-lowering drugs belong to a class of medicines called statins, which work in the liver.
FORBES: Magazine Article
-
All three drugs belong to a class of anti-inflammatory drugs called Cox-2 inhibitors, which ease inflammation without causing the gastrointestinal bleeding that can accompany older pain medicines like ibuprofen and aspirin.
FORBES: Magazine Article
-
Economists are almost completely useuless in this respect because, like reporters and news editors, they belong to the same class of highly paid professionals.
FORBES: How Can You Protect An Entire Economy From Competition?
-
The implication is that, unlike Mrs Arroyo and Mr Aquino (both children of presidents), Mr Villar does not belong to a ruling class that buys financial support with political favours, and that he is wealthy enough to rise above the temptations of corruption.
ECONOMIST: Anyone but Arroyo
-
In recent months, Odinga has made it a priority to reach out to the country's middle class and businessmen, many of whom belong to Kibaki's tribe, the Kikuyu.
NPR: Kenya Leader Re-Elected in Disputed Vote
-
And a group of Democratic pollsters, including Stanley Greenberg and Ruy Teixeira, argued forcefully that the real swing voters in this election are not suburban professionals but the 55% of the population who belong to the white working class.
ECONOMIST: Al Gore, the people��s prince
-
The justices also questioned whether an arbitrator had the power to bind thousands of absent class members, each of whom had signed their own arbitration agreements, to a class action when they might not want to belong to one.
FORBES: Supreme Court Shows Skepticism About Class Arbitration
-
Heart side effects have been a looming concern for Cox-2 inhibitors, the class of drugs to which Vioxx, Celebrex, Bextra and Arcoxia belong.
FORBES: Bad News: Merck Withdraws Arcoxia Application